IKK classic hereby announces that it will conclude non-exclusive discount agreements with all interested and suitable pharmaceutical companies in the period from 01.07.2023 to 30.06.2025 for various active ingredients and combinations of active ingredients in accordance with § 130a para. 8 SGB V on the same, non-negotiable terms. The earliest start date of the contract is 01.07.2023 (deviating from Los Adalimumab 01.08.2023), provided that the signed contract and all necessary evidence, self-declarations and documents are received by IKK classic by 05.06.2023. Thereafter, the following applies: If the documents are received by the 5th of each month in the possible accession period, the 1st of the following month will be the start of the contract. If the documents are received after the 5th of each month in the possible accession period, the 1st of the month after next will be the start of the contract. It is possible to join the agreement at any time during the specified period, but no later than 05.05.2025. For further information, see point VI.3).
Adalimumab; ATC-Code: L04AB04Adalimumab; ATC-Code: L04AB04
Dexamethasone; Ampoules; ATC code: H02AB02Dexamethasone; Ampoules; ATC code: H02AB02
Doxylamin, Kombinationen; ATC-Code: A04AB56Doxylamin, Kombinationen; ATC-Code: A04AB56
Elektrolytlösungen; ATC-Code: B05XAElektrolytlösungen; ATC-Code: B05XA
Empagliflozin; ATC-Code: A10BK03Empagliflozin; ATC-Code: A10BK03
Estradiol; Pflaster; ATC-Code: G03CA03Estradiol; Pflaster; ATC-Code: G03CA03
Felbamat; ATC-Code: N03AX10Felbamat; ATC-Code: N03AX10
Flucloxacillin; ATC code: J01CF05Flucloxacillin; ATC code: J01CF05
Fluorouracil; Creme; ATC-Code: D11AF05Fluorouracil; Creme; ATC-Code: D11AF05
Follitropin Alfa; ATC code: G03GA05Follitropin Alfa; ATC code: G03GA05
Follitropin beta; ATC code: G03GA06Follitropin beta; ATC code: G03GA06
Amphotericin B; ATC-Code: A07AA07Amphotericin B; ATC-Code: A07AA07
Gefitinib; Filmtabletten; ATC-Code: L01EB01Gefitinib; Filmtabletten; ATC-Code: L01EB01
Glucagon; ATC-Code: H04AA01Glucagon; ATC-Code: H04AA01
Goserelin; ATC code: L02AE03Goserelin; ATC code: L02AE03
Lapatinib; ATC-Code: L01EH01Lapatinib; ATC-Code: L01EH01
Leuprorelin; ATC code: L02AE02Leuprorelin; ATC code: L02AE02
Levetiracetam; Infusionslösungskonzentrat; ATC-Code: N03AX14Levetiracetam; Infusionslösungskonzentrat; ATC-Code: N03AX14
mitomycin; ATC code: L01DC03mitomycin; ATC code: L01DC03
Montelukast; Granulat; ATC-Code: R03DC03Montelukast; Granulat; ATC-Code: R03DC03
Natalizumab i.v.; Infusionslösungskonzentrat; ATC-Code: L04AA23Natalizumab i.v.; Infusionslösungskonzentrat; ATC-Code: L04AA23
Nepafenac; ATC-Code: S01BC10Nepafenac; ATC-Code: S01BC10
Atovaquon und Proguanil; ATC-Code: P01BB51Atovaquon und Proguanil; ATC-Code: P01BB51
Polystyrolsulfonat; ATC-Code: V03AE01Polystyrolsulfonat; ATC-Code: V03AE01
Ranolazine; ATC code: C01EB18Ranolazine; ATC code: C01EB18
Tranylcypromine; ATC code: N06AF04Tranylcypromine; ATC code: N06AF04
Zuclopenthixol; ATC code: N05AF05Zuclopenthixol; ATC code: N05AF05
Sapropterin; ATC-Code: A16AX07Sapropterin; ATC-Code: A16AX07
Betamethason; ATC-Code: H02AB01Betamethason; ATC-Code: H02AB01
Bimatoprost und Timolol; Einzeldosispipetten; ATC-Code: S01ED62Bimatoprost und Timolol; Einzeldosispipetten; ATC-Code: S01ED62
Brimonidin und Timolol; ATC-Code: S01ED69Brimonidin und Timolol; ATC-Code: S01ED69
codeine and paracetamol; ATC code: N02AJ06codeine and paracetamol; ATC code: N02AJ06
Cyanocobalamin; ATC-Code: B03BA01Cyanocobalamin; ATC-Code: B03BA01
Denosumab; ATC-Code: M05BX04Denosumab; ATC-Code: M05BX04